De Novo Antibody Design with AI
Harness the Potential of Zero-Shot Generative AI in De Novo Antibody Design
Traditional antibody discovery is time and resource intensive, screening large immune or synthetic libraries. Offering little control over the output sequences, that can result in lead candidates with suboptimal binding or poor developability attributes.
In this technical poster, we demonstrate the potential of zero-shot generative AI to greatly increase the speed, quality, and controllability of antibody design.
Download the poster now for more details.
